Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rockwell Medical (RMTI) Shares Outstanding (Diluted Average): 2020-2024

Historic Shares Outstanding (Diluted Average) for Rockwell Medical (RMTI) over the last 5 years, with Dec 2024 value amounting to $31.1 million.

  • Rockwell Medical's Shares Outstanding (Diluted Average) rose 11.12% to $36.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $36.0 million, marking a year-over-year increase of 11.12%. This contributed to the annual value of $31.1 million for FY2024, which is 33.17% up from last year.
  • Per Rockwell Medical's latest filing, its Shares Outstanding (Diluted Average) stood at $31.1 million for FY2024, which was up 33.17% from $23.3 million recorded in FY2023.
  • In the past 5 years, Rockwell Medical's Shares Outstanding (Diluted Average) registered a high of $75.6 million during FY2020, and its lowest value of $8.5 million during FY2021.
  • Its 3-year average for Shares Outstanding (Diluted Average) is $22.9 million, with a median of $23.3 million in 2023.
  • As far as peak fluctuations go, Rockwell Medical's Shares Outstanding (Diluted Average) slumped by 88.73% in 2021, and later surged by 67.77% in 2022.
  • Rockwell Medical's Shares Outstanding (Diluted Average) (Yearly) stood at $75.6 million in 2020, then crashed by 88.73% to $8.5 million in 2021, then surged by 67.77% to $14.3 million in 2022, then soared by 63.05% to $23.3 million in 2023, then soared by 33.17% to $31.1 million in 2024.